Catubay, Lelia L.
HRN: 24-31-63 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/10/2024
01/17/2024
IV
500 Mg
IVT
Right Hepatic Cyst
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes